Man Group’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,801,336
Closed -$5.38M 782
2022
Q4
$5.38M Hold
1,801,336
0.02% 801
2022
Q3
$5.38M Buy
+1,801,336
New +$4.43M 0.03% 710
2022
Q2
Sell
-1,801,336
Closed -$5.58M 766
2022
Q1
$6.93M Buy
1,801,336
+91,294
+5% +$379K 0.02% 757
2021
Q4
$7.17M Sell
1,710,042
-65,237
-4% -$277K 0.02% 738
2021
Q3
$8.29M Buy
1,775,279
+17,208
+1% +$84.4K 0.03% 647
2021
Q2
$9.39M Buy
1,758,071
+378,765
+27% +$1.98M 0.03% 604
2021
Q1
$6.25M Buy
1,379,306
+758,693
+122% +$3.29M 0.03% 597
2020
Q4
$2.3M Sell
620,613
-8,260
-1% -$31.7K 0.01% 1148
2020
Q3
$2.23M Buy
628,873
+17,514
+3% +$60.7K 0.01% 1159
2020
Q2
$1.9M Sell
611,359
-27,221
-4% -$79.1K 0.01% 1087
2020
Q1
$2.03M Sell
638,580
-269,471
-30% -$1.18M 0.01% 885
2019
Q4
$4.54M Hold
908,051
0.01% 1033
2019
Q3
$4.39M Buy
908,051
+8,410
+0.9% +$44.1K 0.02% 939
2019
Q2
$5.2M Buy
899,641
+200,000
+29% +$1.32M 0.02% 930
2019
Q1
$4.91M Sell
699,641
-8,842
-1% -$58.4K 0.02% 932
2018
Q4
$4.57M Buy
708,483
+5,880
+0.8% +$37.6K 0.02% 817
2018
Q3
$4.91M Sell
702,603
-123,138
-15% -$925K 0.02% 1007
2018
Q2
$7.84M Buy
825,741
+192,231
+30% +$1.84M 0.03% 713
2018
Q1
$6.46M Buy
+633,510
New +$6.47M 0.03% 711

Other funds holding CO

Man Group's CO Position: Q1 2023 in Review

Man Group sold out of Global Cord Blood Corporation (CO) in Q1 2023, closing a stake of 1,801,336 shares — an estimated $5.38M sold.

Man Group first reported a position in CO in Q1 2018 and held it in 19 quarters. The position peaked at $9.39M in Q2 2021. 23 funds tracked by Wall St. Rank hold CO as of Q1 2023.

  • Man Group reported no remaining Global Cord Blood Corporation position as of Q1 2023 after selling out during the quarter.
  • Man Group sold 1,801,336 Global Cord Blood Corporation shares in Q1 2023, an estimated $5.38M.
  • Man Group first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 19 quarters.
  • Man Group's Global Cord Blood Corporation position peaked at $9.39M in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.